Zydus to market TLC’s mucormycosis drug in India

Pharmaceutical and healthcare major Zydus Cadila and Taiwan’s specialty pharmaceutical company TLC on Wednesday announced that they have signed an agreement to market liposomal amphotericin B in India. That is a critical drug to treat mucormycosis or black fungus.

from Ahmedabad News, Latest Ahmedabad News Headlines & Live Updates - Times of India https://ift.tt/3frvj4W